These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 34067536

  • 1. Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.
    Kim BS.
    Int J Mol Sci; 2021 May 17; 22(10):. PubMed ID: 34067536
    [Abstract] [Full Text] [Related]

  • 2. Critical role of TLR activation in viral replication, persistence, and pathogenicity of Theiler's virus.
    Kim BS.
    Front Immunol; 2023 May 17; 14():1167972. PubMed ID: 37153539
    [Abstract] [Full Text] [Related]

  • 3. IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease.
    Bowen JL, Olson JK.
    Viral Immunol; 2013 Aug 17; 26(4):223-38. PubMed ID: 23829778
    [Abstract] [Full Text] [Related]

  • 4. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Jin YH, Kang HS, Hou W, Meng L, Kim BS.
    J Virol; 2015 Feb 17; 89(3):1867-78. PubMed ID: 25428872
    [Abstract] [Full Text] [Related]

  • 5. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease.
    Palma JP, Kwon D, Clipstone NA, Kim BS.
    J Virol; 2003 Jun 17; 77(11):6322-31. PubMed ID: 12743289
    [Abstract] [Full Text] [Related]

  • 6. TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection.
    Jin YH, Kaneyama T, Kang MH, Kang HS, Koh CS, Kim BS.
    J Neuroinflammation; 2011 Dec 21; 8():178. PubMed ID: 22189096
    [Abstract] [Full Text] [Related]

  • 7. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.
    Zheng L, Calenoff MA, Dal Canto MC.
    J Neuroimmunol; 2001 Aug 30; 118(2):256-67. PubMed ID: 11498260
    [Abstract] [Full Text] [Related]

  • 8. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.
    Duncan DS, Miller SD.
    PLoS One; 2011 Apr 08; 6(4):e18548. PubMed ID: 21494618
    [Abstract] [Full Text] [Related]

  • 9. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3.
    So EY, Kang MH, Kim BS.
    Glia; 2006 Jun 08; 53(8):858-67. PubMed ID: 16586493
    [Abstract] [Full Text] [Related]

  • 10. The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
    Gilli F, Li L, Pachner AR.
    J Neurovirol; 2016 Feb 08; 22(1):66-79. PubMed ID: 26260496
    [Abstract] [Full Text] [Related]

  • 11. IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
    Kim BS, Jin YH, Meng L, Hou W, Kang HS, Park HS, Koh CS.
    J Neuroinflammation; 2012 Sep 17; 9():217. PubMed ID: 22985464
    [Abstract] [Full Text] [Related]

  • 12. Innate immune response induced by Theiler's murine encephalomyelitis virus infection.
    Kim BS, Palma JP, Kwon D, Fuller AC.
    Immunol Res; 2005 Sep 17; 31(1):1-12. PubMed ID: 15591618
    [Abstract] [Full Text] [Related]

  • 13. Rapid Expansion of Virus-Specific CD4+ T Cell Types in the CNS of Susceptible Mice Infected with Theiler's Virus.
    Kang HS, Hou W, Kim BS.
    Int J Mol Sci; 2020 Oct 19; 21(20):. PubMed ID: 33086489
    [Abstract] [Full Text] [Related]

  • 14. Effects of Keratinocyte-Derived Cytokine (CXCL-1) on the Development of Theiler's Virus-Induced Demyelinating Disease.
    Kang MH, Jin YH, Kim BS.
    Front Cell Infect Microbiol; 2018 Oct 19; 8():9. PubMed ID: 29410948
    [Abstract] [Full Text] [Related]

  • 15. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Burt RK, Padilla J, Dal Canto MC, Miller SD.
    Blood; 1999 Oct 15; 94(8):2915-22. PubMed ID: 10515897
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease.
    Kim SJ, Jin YH, Kim BS.
    PLoS One; 2017 Oct 15; 12(4):e0176406. PubMed ID: 28445497
    [Abstract] [Full Text] [Related]

  • 17. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination.
    Palma JP, Yauch RL, Lang S, Kim BS.
    J Immunol; 1999 Jun 01; 162(11):6543-51. PubMed ID: 10352270
    [Abstract] [Full Text] [Related]

  • 18. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology.
    Begolka WS, Haynes LM, Olson JK, Padilla J, Neville KL, Dal Canto M, Palma J, Kim BS, Miller SD.
    J Neurovirol; 2001 Oct 01; 7(5):409-20. PubMed ID: 11582513
    [Abstract] [Full Text] [Related]

  • 19. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL, Olson JK.
    J Immunol; 2009 Dec 01; 183(11):6971-80. PubMed ID: 19890055
    [Abstract] [Full Text] [Related]

  • 20. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice.
    Myoung J, Bahk YY, Kang HS, Dal Canto MC, Kim BS.
    J Virol; 2008 Jun 01; 82(11):5606-17. PubMed ID: 18353953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.